A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s12032-015-0715-7
Published Online: 2015-11-24
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tamiya, Motohiro
Tamiya, Akihiro
Kaneda, Hiroyasu
Nakagawa, Kazuhiko
Yoh, Kiyotaka
Goto, Koichi
Okamoto, Hiroaki
Shimokawa, Tsuneo
Abe, Tetsuya
Tanaka, Hiroshi
Daga, Haruko
Takeda, Koji
Hirashima, Tomonori
Atagi, Shinji
Text and Data Mining valid from 2015-11-24